Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel Gene expression-based Risk Stratification tool predicts recurrence in Non-muscle invasive Bladder cancer

22 May 2025

Abstract excerpt

BACKGROUND: Bladder cancer represents a heterogeneous disease with distinct clinical challenges. Non-muscle invasive bladder cancer (NMIBC) typically presents as indolent and slow-growing, yet a critical clinical challenge remains: identifying which patients will progress to muscle-invasive disease requiring radical interventions. Early detection of progression propensity is essential, as once muscle invasion...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Ferroptosis and cancer prognosis
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40405063
DOI: 10.1186/s12885-025-14273-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel Gene expression-based Risk Stratification tool predicts recurrence in Non-muscle invasive Bladder cancerPMID 40405063Read ↗

Novel Gene expression-based Risk Stratification tool predicts recurrence in Non-muscle invasive Bladder cancerSemantic proximity Read ↗

Long non-coding RNAs to predict postoperative recurrence in muscle-invasive bladder cancer and to develop a new molecular classification systemSemantic proximity Read ↗

Development and Validation of a Prognostic Nomogram Model for Recurrence of Non-Muscle Invasive Bladder CancerSemantic proximity Read ↗

Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancer.Semantic proximity Read ↗

The consensus molecular classification of muscle-invasive bladder cancerSemantic proximity Read ↗

Identification of muscle-invasive related genes in bladder cancer single-cell sequencing data for constructing patient prognostic modelSemantic proximity Read ↗

Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.Semantic proximity Read ↗

Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non–muscle-invasive Bladder CancerSemantic proximity Read ↗

An integrated molecular classification system identifies distinct prognostic clusters of non-muscle-invasive bladder cancer.Semantic proximity Read ↗

Integrating transcriptomics, single-cell omics, and deep learning-based histopathological features to identify OLFML3 as in bladder cancerSemantic proximity Read ↗

Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study.Semantic proximity Read ↗

Advances in risk stratification of bladder cancer to guide personalized medicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.